ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0352

Fast-tracking Axial Spondyloarthritis Diagnosis: A Novel Approach to Public Health Advocacy and Awareness

Joe Eddison, National Axial Spondyloarthritis Society, London, United Kingdom

Meeting: ACR Convergence 2024

Keywords: Access to care, Ankylosing spondylitis (AS), primary care, spondyloarthritis, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Patient Education/Community Programs Poster – ARP

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The Act on Axial SpA campaign is dedicated to minimising the lengthy 8.5-year delay in diagnosing axial spondyloarthritis (axial SpA) by implementing a pioneering Gold Standard diagnosis time of just one year. Collaborating with the Belfast Health & Social Care Trust, our initiative aims to streamline the patient journey from symptom onset to diagnosis through a comprehensive, integrated intervention package. By enhancing awareness of Axial SpA and optimising diagnostic procedures alongside specialist care pathways, our pilot project endeavours to abbreviate the time to diagnosis, thereby serving as a blueprint for broader implementation across healthcare systems.

Methods: In partnership with a specialist Belfast-based creative agency, we devised a geo-targeted, multi-channel media campaign to bolster public awareness. Our strategy encompassed out-of-home advertising, radio promotions, and targeted social media adverts. The campaign featured 85 out-of-home advertising panels across 85 locations, radio slots on Cool FM, and geographically tailored social media adverts on Facebook and Instagram. Spanning six weeks during January and February 2024, we meticulously tracked the campaign’s performance through standard social media and digital analytics platforms.

Results: Our campaign resonated strongly with individuals experiencing low back pain, prompting them to take action by utilising the NASS symptom checker. Over the six-week period, our social media outreach amassed an impressive 995,399 impressions and reached 831,390 individuals. Out-of-home advertising achieved an 81% reach among 18–40-year-olds in Belfast, engaging over 88,000 individuals. Additionally, radio partnership adverts reached more than 565,000 adults across Northern Ireland. (See figure 1)

This extensive reach translated into robust engagement metrics:

  • Social media ads garnered 16,799 clicks and 227,158 engagements.
  • Radio advertising led to 2,390 readership engagements on Cool FM.
  • The Act on Axial SpA website witnessed a surge in traffic, with 2,976 users from Belfast visiting during the campaign, compared to 285 in the entirety of 2023.
  • Remarkably, the NASS symptom checker experienced a staggering 4,389% increase in average daily completions during the campaign. (See figure 1)

Conclusion: Our findings demonstrate the efficacy of engaging individuals with longstanding low back pain through innovative, visually compelling marketing materials infused with public health messaging. Moreover, early clinical data suggests that heightened public awareness can be achieved without overwhelming the healthcare system, while expediting patients’ journeys towards diagnosis. By continuing to monitor referrals and diagnoses, we aim to assess the long-term impact of our campaign on addressing delays in axial SpA diagnosis.

Supporting image 1

Figure 1 – Infographics on the campaign results. (Source: Google Analytics, Meta Analytics)

Supporting image 2

Figure 2 – Number of people completing the NASS symptom checker in Belfast. (Source: Google Analytics)


Disclosures: J. Eddison: None.

To cite this abstract in AMA style:

Eddison J. Fast-tracking Axial Spondyloarthritis Diagnosis: A Novel Approach to Public Health Advocacy and Awareness [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/fast-tracking-axial-spondyloarthritis-diagnosis-a-novel-approach-to-public-health-advocacy-and-awareness/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fast-tracking-axial-spondyloarthritis-diagnosis-a-novel-approach-to-public-health-advocacy-and-awareness/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology